| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > Why Avoiding Human Resources is the Only Way to Land a Pharmaceutical Sales Job |
|
Advice You - Why Avoiding Human Resources is the Only Way to Land a Pharmaceutical Sales Job
One of the best business analogies I’ve ever heard compares businesses to boats. Small businesses a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product re like small boats. The have the luxury of being quick to respond, controlled by just a handful of ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in eople, and communication is as simple as turning over your shoulder and saying, “Land ho!” On the ot lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. er hand, they don’t have some of the luxuries that big businesses have. Big boats [businesses] are p here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe werful, they have many redundant features – small breeches in the hull aren’t as threatening, and mo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro entum goes anything but unnoticed. What big business doesn’t have is the ability to respond quickly ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc . Communication is often complex, becomes confusing and is often lost. Nearly every pharmaceutical c easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi mpany with a sales force is the equivalent of a big boat. Don’t get me wrong here; human resources nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically fficers and internal recruiters do a wonderful job. But if you want a job in the kitchen of a cruise and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ship, who would you talk to, the first mate or the head chef? In many pharmaceutical companies, inte ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nal recruiters are a branch of human resources. They make recommendations on hiring, they handle ini ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tial screenings, they sift through resumes, and they facilitate the tons of paperwork involved in th dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod hiring process. What they don’t do is make the final decision. In the end, pharmaceutical companie cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin aren’t just big boats. They are some of the biggest boats in the sea of American business. They are tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen multi-billion dollar companies that turn very slowly, respond sluggishly to small stimuli, and const t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ntly struggle with the flow of communication. It’s neither good nor bad. It’s just the nature of bei ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ng a titanic company (sorry for the pun). Getting on board such a colossal ship is, in and of it sel y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products , no small feat. Spend time networking with pharmaceutical sales representatives and district manag . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de rs. Doing so will prove invaluable every step of the way. In many cases, they will help you decide i elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip you even want to be on the ship in the first place – chances are it’s not as glamorous as you think tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Focus on Undergraduate Course in Risk Management and Insurance Managing Small Business Finances Opportunities Abound for Those with Medical Degrees
|